This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Carcinoma in situ of skin of lip
CD2_INSITU_SKIN_LIP_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleNone |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D04
- Name in latin
- Carcinoma in situ cutis labii (oris)
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of skin of lip
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of skin of lip
- In situ neoplasms
- In situ neoplasms
- Neoplasms
- Any operation in hilmo
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 97 | 38 | 59 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.03 |
| Median age at first event (years) | 73.30 | 73.96 | 72.88 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 88
- Matched controls
- 881
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D04.0
ICD-10 Finland
Carcinoma in situ: Skin of lip
+∞
126.7
88
*
L57.0
ICD-10 Finland
Actinic keratosis
45.8
45.8
59
37
TQW99
NOMESCO Finland
Other minor procedure on skin
74.7
37.3
41
10
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
31.7
37.1
52
38
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
469.7
33.2
31
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
45.3
32.0
39
15
ZXC20
NOMESCO Finland
Use of chemical agents
382.7
28.5
27
*
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
127.5
26.4
27
*
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
+∞
25.2
23
*
EAA10
NOMESCO Finland
Excision of lesion of lip
90.6
24.4
26
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
+∞
22.9
21
*
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
51.6
22.3
26
7
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
21.7
20
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
19.5
18
*
ZQZ00
NOMESCO Finland
Treatment of several skin areas
+∞
19.5
18
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
27.7
19.2
26
13
R23.8
ICD-10 Finland
Other and unspecified skin changes
13.1
18.6
35
42
L56.8
ICD-10 Finland
Other specified acute skin changes due to ultraviolet radiation
+∞
18.4
17
*
ZZR00
NOMESCO Finland
Flap of skin
111.6
17.3
18
*
D04.5
ICD-10 Finland
Carcinoma in situ: Skin of trunk
207.5
17.1
17
*
Z2221
NOMESCO Finland
Medical doctor
6.9
15.5
50
140
C44.02
ICD-10 Finland
Spinocellular carcinoma of the lip skin
+∞
13.9
13
*
EAA30
NOMESCO Finland
Partial excision of lower lip
+∞
13.9
13
*
D06BB10
ATC
imiquimod; topical
23.7
13.6
19
10
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
34.5
13.5
17
6
ZXD10
NOMESCO Finland
Scheduled procedure
5.4
12.4
55
208
ZXC10
NOMESCO Finland
Use of laser
35.6
12.1
15
5
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
11.7
11
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
11.3
11.6
22
25
Z3231
NOMESCO Finland
Registered nurse
5.1
11.4
47
161
R4110
NOMESCO Finland
Physiotherapy
5.2
11.2
44
142
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
124.1
10.7
11
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
124.1
10.7
11
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
10.6
10
*
116
Kela drug reimbursment
Prostate cancer
+∞
10.6
10
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
9.5
9
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
9.5
9
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
+∞
9.5
9
*
XF400
NOMESCO Finland
ECG with 12 standard connections
4.6
8.7
35
111
D04.6
ICD-10 Finland
Carcinoma in situ: Skin of upper limb, including shoulder
99.0
8.6
9
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
99.0
8.6
9
*
Z3226
NOMESCO Finland
Physiotherapist
4.8
8.5
32
94
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
+∞
8.5
8
*
WX002
NOMESCO Finland
Sedation and analgesia
4.5
8.4
34
108
ZXE00
NOMESCO Finland
One hour or less
3.8
8.1
48
212
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
17.1
8.0
12
8
D04.4
ICD-10 Finland
Carcinoma in situ: Skin of scalp and neck
49.5
7.9
9
*
ZXA05
NOMESCO Finland
Left side
3.9
7.7
41
162
ZXC50
NOMESCO Finland
Cryotherapy
17.7
7.4
11
7
C44.62
ICD-10 Finland
Spinocellular carcinoma of the skin of the upper extremity including the shoulder
+∞
7.4
7
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
7.4
7
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
7.4
7
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
7.4
7
*
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
+∞
7.4
7
*
D07AB08
ATC
desonide; topical
5.4
7.0
21
48
J01DB01
ATC
cefalexin; oral
4.4
6.5
77
540
ZXE10
NOMESCO Finland
More than one and less than three hours
3.3
6.4
43
199
S18
ICPC
Laceration/cut
3.2
6.3
50
258
DAB10
NOMESCO Finland
Partial excision of auricle
+∞
6.3
6
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
6.3
6
*
Y77
ICPC
Malignant neoplasm prostate
+∞
6.3
6
*
8070/3-C44.2
ICD-O-3
Squamous cell carcinoma, NOS, of external ear
+∞
6.3
6
*
130
Kela drug reimbursment
Malignant tumour
+∞
6.3
6
*
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
11.2
6.2
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002256) Pathology report gross observation
40
53
12.14
31.00
2.6
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
70
192
10.51
28.89
5.2
1.6
—
—
—
0
0
(4035726)
22
18
15.51
22.88
1.2
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
42
128
5.02
13.46
3.6
2.6
e6/l
0.6
1.2
0.90
25
69
(40768443) Skin Pathology biopsy report
18
24
8.98
13.17
1.3
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
40
127
4.66
11.99
3.7
2.8
e6/l
2.7
2.3
0.06
23
67
(3000991) Gas panel - Venous blood
24
56
5.37
10.27
7.0
8.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
55
269
3.41
8.18
5.1
3.6
e6/l
51.8
94.4
0.56
40
191
(36304419) Bacteria [Presence] in Urine
45
196
3.42
8.06
4.7
2.9
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
47
214
3.32
7.77
4.6
2.8
e6/l
0.7
0.4
0.30
36
152
(3002582) Erythrocytes [#/volume] in Urine
50
239
3.25
7.58
4.6
2.9
e6/l
132.6
334.2
0.32
40
181
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
53
264
3.22
7.47
4.7
3.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
38
157
3.34
7.29
8.7
4.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
25
82
3.76
6.79
2.2
1.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
35
151
3.06
6.10
2.2
3.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
24
83
3.51
5.98
2.3
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
22
72
3.66
5.95
1.6
1.5
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
15
37
4.61
5.87
2.7
2.0
g/l
1.8
1.6
0.36
15
32
(3003338) MCHC [Mass/volume]
80
557
3.49
5.56
39.0
20.3
g/l
329.2
331.4
1.15
80
549
(3024561) Albumin [Mass/volume] in Serum or Plasma
55
318
2.68
5.37
5.4
3.2
g/l
34.4
34.5
0.04
49
288
(3012544) pH of Venous blood
23
83
3.32
5.33
5.3
3.9
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
15
42
4.04
4.99
4.2
7.7
mmol/l
25.0
24.7
0.08
15
35
(3002385) Erythrocyte distribution width [Ratio]
77
542
3.04
4.89
36.8
18.0
%
14.2
13.8
1.51
77
520
(3012095) Magnesium [Moles/volume] in Serum or Plasma
26
107
2.95
4.81
2.4
2.7
mmol/l
0.8
0.8
0.83
26
100
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
34
163
2.67
4.73
3.1
2.1
—
—
—
0
0
(3015736) pH of Urine
47
274
2.39
4.24
2.4
3.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
80
596
2.95
4.18
35.4
16.3
%
39.1
39.6
0.32
63
356
(3022948) Iron [Moles/volume] in Serum or Plasma
28
129
2.65
4.15
3.9
2.4
umol/l
11.5
11.8
0.10
28
116
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
18
65
3.17
4.12
3.1
2.0
umol/l
6.4
7.3
0.29
18
57
(3037467) Urinalysis macro (dipstick) panel - Urine
70
492
2.52
4.06
5.1
4.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
15
49
3.44
4.01
1.8
1.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
48
291
2.29
3.87
4.7
3.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
16
56
3.22
3.84
1.5
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
49
301
2.27
3.81
2.2
2.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
53
340
2.23
3.67
8.5
4.5
e9/l
0.6
0.6
0.14
45
286
(42870588) Differential panel, method unspecified - Blood
41
237
2.26
3.66
7.5
4.9
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
18
70
2.93
3.63
7.7
6.9
mmol/l
13.0
11.9
0.24
18
63
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
36
3.66
3.61
7.4
8.4
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
53
342
2.21
3.60
8.5
4.5
e9/l
0.0
0.0
0.52
44
292
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
14
47
3.31
3.58
1.6
1.3
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
56
371
2.21
3.54
12.3
5.3
e9/l
4.7
4.7
0.06
50
319
(3003396) Base excess in Arterial blood by calculation
22
97
2.64
3.52
6.1
6.1
mmol/l
1.2
1.5
0.06
16
74
(3019198) Lymphocytes [#/volume] in Blood
53
345
2.18
3.49
8.8
4.6
e9/l
1.9
1.8
0.11
45
297
(3021589) Normoblasts [#/volume] in Blood
47
293
2.17
3.44
11.4
8.0
e9/l
0.0
0.0
0.49
40
233
(3044640) Blood type and Crossmatch panel - Blood
38
219
2.21
3.37
3.4
2.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
25
120
2.46
3.36
2.2
1.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
53
352
2.11
3.24
2.9
2.1
pmol/l
92.4
91.2
0.06
28
181
(3013115) Eosinophils [#/volume] in Blood
53
353
2.11
3.20
8.7
4.5
e9/l
0.1
0.2
1.88
45
303
(3007853) Bacteria identified in Skin by Aerobe culture
20
88
2.60
3.20
2.3
1.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
8
16
5.34
3.12
2.1
3.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
18
77
2.64
3.04
1.2
2.3
e9/l
73.7
60.8
—
7
65
(3044889) 12 lead EKG panel
69
515
2.18
3.01
5.2
4.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
9
22
4.40
2.96
1.1
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
18
79
2.57
2.89
1.8
3.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
35
206
2.09
2.87
3.1
2.1
mg/l
3.1
2.8
0.29
30
174
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
8
18
4.74
2.86
1.3
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
21
101
2.38
2.79
1.9
1.6
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
15
4.94
2.65
1.3
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
15
4.94
2.65
1.3
1.4
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
15
4.94
2.65
2.0
2.1
%
60.1
70.9
—
7
15
(3023368) Bacteria identified in Blood by Culture
36
220
2.01
2.64
6.1
4.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
11
39
3.05
2.57
1.6
1.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
70
544
2.03
2.49
9.3
4.9
u/l
74.3
77.0
0.32
65
497
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
80
654
2.27
2.48
27.9
14.1
ml/min/173m2
65.4
70.5
1.10
64
539
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
11
40
2.97
2.47
1.6
1.3
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
9
27
3.57
2.46
1.1
1.1
g/l
0.0
0.0
—
9
22
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
8
6.51
2.40
3.0
4.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
10
36
2.98
2.28
1.3
8.0
mmol/l
26.8
24.6
—
10
36
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
9
30
3.20
2.21
1.1
1.1
g/l
0.0
0.0
—
9
25
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
37
2.90
2.18
1.1
1.1
g/l
10.1
10.5
—
10
28
(3026008) Bacteria identified in Urine by Culture
36
233
1.87
2.17
4.1
3.3
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
86
739
2.44
2.12
31.3
18.2
umol/l
100.7
86.4
1.16
86
739
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
22
356
0.51
2.08
4.4
4.1
ng/l
25.1
54.6
1.79
17
270
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
9
33
2.90
1.99
1.1
1.1
g/l
0.7
0.0
—
9
26
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
9
33
2.90
1.99
1.1
1.1
g/l
34.0
37.1
—
9
24
(3009445) Proteinase 3 Ab [Units/volume] in Serum
8
27
3.13
1.98
1.3
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
32
205
1.84
1.97
3.5
2.4
umol/l
14656.5
6401.6
0.24
26
170
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
46
2.57
1.93
2.3
2.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
37
250
1.78
1.91
4.5
3.2
mg/l
109.8
309.1
0.35
25
164
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
10
40
2.67
1.90
2.4
2.2
%
1.0
1.1
—
10
40
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
48
2.46
1.78
1.3
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
18
3.48
1.77
3.0
1.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
42
2.54
1.74
1.1
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
25
155
1.83
1.68
1.4
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
85
751
2.07
1.55
31.7
19.0
mmol/l
138.7
139.8
2.80
85
721
(3023103) Potassium [Moles/volume] in Serum or Plasma
85
752
2.05
1.53
32.5
19.1
mmol/l
4.0
4.0
0.95
85
723
(3049717) Cytology report of Urine Cyto stain
7
28
2.61
1.48
1.7
1.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
29
195
1.69
1.48
3.3
2.8
u/l
32.9
31.1
0.15
29
185
(36660697) Celiac disease serology panel - Serum
10
46
2.31
1.45
1.0
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
81
710
1.85
1.44
25.6
14.9
mg/l
33.4
24.2
1.29
65
563
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
9
41
2.31
1.41
1.1
1.1
g/l
3.8
3.2
—
9
28
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
5
18
2.87
1.30
1.8
1.2
—
—
—
0
0
(3013512) EKG study
17
263
0.57
1.27
4.4
4.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
36
265
1.57
1.27
5.3
4.0
mg/mmol
24.4
7.8
0.48
23
171
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
25
2.49
1.26
1.0
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
6
25
2.49
1.26
1.2
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
12
64
2.00
1.24
1.3
1.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
85
767
1.87
1.21
39.0
21.6
fl
92.1
91.8
0.28
85
744
(3000963) Hemoglobin [Mass/volume] in Blood
85
768
1.86
1.19
39.3
21.8
g/l
128.4
134.1
2.59
85
744
(3035941) MCH [Entitic mass]
85
768
1.86
1.19
38.9
21.6
pg
30.5
30.5
0.02
85
745
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
20
2.58
1.16
1.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
20
2.58
1.16
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
20
2.58
1.16
1.0
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
21
2.45
1.10
2.2
4.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
7
33
2.21
1.08
3.3
3.2
pmol/l
4.0
4.3
—
7
28
(3013139) Helicobacter pylori Ag [Presence] in Stool
9
46
2.05
1.07
1.0
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
82
741
1.69
1.04
15.3
9.0
u/l
21.5
23.0
0.69
82
704
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
5
22
2.34
1.04
1.0
1.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
54
448
1.46
1.03
5.6
4.8
mmol/l
6.9
7.0
0.22
54
416
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
30
0.00
0.99
0.0
1.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
27
196
1.52
0.99
5.0
2.7
ug/l
0.6
0.8
0.56
19
139
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
32
0.00
0.97
0.0
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
7
37
1.96
0.96
4.0
4.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
8
42
1.98
0.91
3.4
2.2
g/l
8.1
11.1
—
8
34
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
10
58
1.81
0.83
1.3
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
5
23
2.24
0.77
4.0
2.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
10
60
1.74
0.75
6.2
4.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
17
119
1.52
0.73
1.6
1.3
g/l
2.5
2.9
—
5
59
(3025941) Bacteria identified in Stool by Culture
5
28
1.83
0.67
1.0
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
15
207
0.67
0.66
5.4
3.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
14
193
0.68
0.61
1.4
1.8
pmol/l
459.6
437.8
—
9
158
(3000492) Spirometry study
8
52
1.59
0.61
1.3
1.5
—
—
—
0
0
(4094501)
0
22
0.00
0.60
0.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
35
1.76
0.59
1.0
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
9
60
1.55
0.56
1.1
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
9
63
1.47
0.54
1.1
1.6
nmol/l
471.1
379.5
—
9
57
(40768797) Stomach Pathology biopsy report
13
93
1.46
0.51
1.5
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
78
730
1.35
0.50
19.1
14.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6
92
0.63
0.45
15.0
8.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
5
32
1.59
0.43
1.8
1.8
mmol/l
22.8
25.5
—
5
24
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
15
0.00
0.41
0.0
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
0.2
—
0
16
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
0
17
0.00
0.41
0.0
1.2
—
1.1
—
0
17
(3022145) Colonoscopy Study observation
9
67
1.38
0.39
1.1
1.3
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
6
44
1.39
0.35
2.5
2.5
e6/l
0.0
0.2
—
6
44
(3022621) pH of Urine by Test strip
7
53
1.35
0.31
2.1
2.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
32
287
1.17
0.25
8.4
3.7
%
21.8
25.3
0.69
13
150
(3041096) Erythrocytes [Presence] in Urine by Automated
16
186
0.83
0.21
3.7
3.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.0
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
5
65
0.76
0.17
4.4
2.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
24
262
0.89
0.14
3.8
4.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
11
124
0.87
0.09
7.4
3.8
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
5
60
0.82
0.08
4.0
3.9
kpa
4.9
5.2
—
5
54
(3030905) Polymorphonuclear cells [#/volume] in Blood
0
9
0.00
0.00
0.0
1.3
—
6.0
—
0
9
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
9
0.00
0.00
0.0
1.6
—
32.8
—
0
9
(4010399)
5
54
0.92
0.00
1.8
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
0
9
0.00
0.00
0.0
3.0
—
66.7
—
0
9
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
5
0.00
0.00
0.0
2.2
—
2490.0
—
0
5
(3017704) Immunofixation for Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(4062490)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009343) pH of Capillary blood
5
57
0.87
0.00
4.0
4.1
—
7.4
—
0
5
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
65.1
—
0
8
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
0
5
0.00
0.00
0.0
5.4
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
30.5
—
0
6
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(4281824)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
10
100
1.00
0.00
3.1
2.6
ug/l
12.1
9.5
—
10
86
(4268621)
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
2.1
—
0
6
(3017315) Amylase [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
250.8
—
0
5
(40757494) Bilirubin.total [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.6
—
329.8
—
0
5
(3004616) Nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
5
59
0.84
0.00
2.4
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
6
0.00
0.00
0.0
4.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_SKIN_LIP_EXALLC – Carcinoma in situ of skin of lip
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).